Selective patient and public involvement: The promise and perils of pharmaceutical intervention for autism.
Annemarie JutelSandy StarrChris ElphickRaffaele RodognoIlina SinghPublished in: Health expectations : an international journal of public participation in health care and health policy (2017)
This case illustrates what we term "selective PPI" where only a sympathetic and/or limited patient viewpoint is included. Findings highlight the perils of using selective PPI to legitimise scientific endeavours, and the possibilities for constructive dialogue.